Jump to content

5-MeO-MET

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Meodipt (talk | contribs) at 09:13, 29 August 2021. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

5-MeO-MET
Identifiers
  • N-Ethyl-2-(5-methoxy-1H-indol-3-yl)-N-methylethan-1-amine
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H20N2O
Molar mass232.327 g·mol−1
3D model (JSmol)
  • CCN(CCc1c[nH]c2c1cc(OC)cc2)C
  • InChI=1S/C14H20N2O/c1-4-16(2)8-7-11-10-15-14-6-5-12(17-3)9-13(11)14/h5-6,9-10,15H,4,7-8H2,1-3H3
  • Key:AVECDEWGCOLCPZ-UHFFFAOYSA-N

5-MeO-MET (5-Methoxy-N-methyl-N-ethyltryptamine) is a recreational designer drug from the substituted tryptamine family, reated to compounds such as N-Methyl-N-ethyltryptamine and 5-MeO-DMT. It was first synthesised in the 1960s and was studied to a limited extent,[1][2] but was first identified on the illicit market in June 2012 in Sweden.[3] It was made illegal in Norway in 2013,[4] and is controlled under analogue provisions in numerous other jurisdictions.

See also


References

  1. ^ Gessner PK, Godse DD, Krull AH, McMullan JM. Structure-activity relationships among 5-methoxy-N:N-dimethyltryptamine, 4-hydroxy-N:N-dimethyltryptamine (psilocin) and other substituted tryptamines. Life Sci., 1 Mar 1968, 7(5): 267–277. doi:10.1016/0024-3205(68)90200-2
  2. ^ Glennon RA, Gessner PK. Serotonin receptor binding affinities of tryptamine analogues. J. Med. Chem., 1 Jan 1979, 22 (4), pp 428–432. doi:10.1021/jm00190a014
  3. ^ EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012
  4. ^ Forskrift om endring i forskrift om narkotika


Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=5-MeO-MET&oldid=1041222675"